|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Restructuring charges | |||||
| Restructuring and asset impairment charges | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income, net | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Loss on partial settlement of convertible notes | |||||
| Total other income, net | |||||
| Income before income taxes | |||||
| Income tax provision | |||||
| Net income | |||||
| Net income per share: | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Shares used in per share calculation: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
